Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)

Clinical trial NCT03201185 · UNKNOWN

Trial details

NCT number: NCT03201185
Sponsor: Hospital Clínico Universitario de Valladolid
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Transcatheter Aortic Valve Replacemen Angiotensin-Converting Enzyme Inhibitors

Start date: 2018-02-10
Primary completion: 2021-08-13
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.